Magenta therapeutics to participate in panel discussion at the 2022 wedbush pacgrow healthcare conference

Cambridge, mass., aug. 02, 2022 (globe newswire) -- magenta therapeutics (nasdaq: mgta), a clinical-stage biotechnology company developing novel medicines designed to bring the curative power of stem cell transplant to more patients, today announced that the company will participate in a gene modulation panel discussion at the 2022 wedbush pacgrow healthcare conference, to be held virtually, on tuesday, august 9th, 2022 at 9:45 a.m. et.
DNTH Ratings Summary
DNTH Quant Ranking